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Purpose
Abstract To determine the validity of the Australian clinical prediction tool Criteria for Screening and Triaging to Appro-
priate aLternative care (CRISTAL) based on objective clinical criteria to accurately identify risk of death within 3 months 
of admission among older patients.
Methods Prospective study of ≥ 65 year-olds presenting at emergency departments in five Australian (Aus) and four Dan-
ish (DK) hospitals. Logistic regression analysis was used to model factors for death prediction; Sensitivity, specificity, area 
under the ROC curve and calibration with bootstrapping techniques were used to describe predictive accuracy.
Results 2493 patients, with median age 78–80 years (DK–Aus). The deceased had significantly higher mean CriSTAL 
with Australian mean of 8.1 (95% CI 7.7–8.6 vs. 5.8 95% CI 5.6–5.9) and Danish mean 7.1 (95% CI 6.6–7.5 vs. 5.5 95% CI 
5.4–5.6). The model with Fried Frailty score was optimal for the Australian cohort but prediction with the Clinical Frailty 
Scale (CFS) was also good (AUROC 0.825 and 0.81, respectively). Values for the Danish cohort were AUROC 0.764 with 
Fried and 0.794 using CFS. The most significant independent predictors of short-term death in both cohorts were advanced 
malignancy, frailty, male gender and advanced age. CriSTAL’s accuracy was only modest for in-hospital death prediction 
in either setting.
Conclusions The modified CriSTAL tool (with CFS instead of Fried’s frailty instrument) has good discriminant power 
to improve prognostic certainty of short-term mortality for ED physicians in both health systems. This shows promise in 
enhancing clinician’s confidence in initiating earlier end-of-life discussions.
Keywords Risk assessment · Uncertainty · Prognosis · Frail · Aged · Prospective studies
Introduction
Background
Older people with frailty, cognitive impairment and concur-
rent chronic illness comprise increasing proportions of hos-
pitalizations and emergency department (ED) presentations 
[1, 2]. Clinicians managing these older people are often 
faced with the task of recognizing dying and preparing 
patients and their families for a transition to less active treat-
ment after acceptance of poor prognosis [3]. But uncertainty 
about chances of survival—almost inevitable in medicine—
can delay appropriate management and may lead to non-
beneficial interventions [4], social admissions [5], or not 
medically justified hospitalizations [6].
Predictive tools for older patients [7] may reduce uncer-
tainty but perform inadequately in discriminating risk of 
death. Some indices have better predictive accuracy but rely 
on laboratory-based data [8]. Screening for palliative care 
needs in the ED is reported to be feasible and improve refer-
rals in research settings [9] but it is not a widespread practice 
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in routine care. The Criteria for Screening and Triaging to 
Appropriate aLternative care (CriSTAL tool) was developed 
to identify short-term risk of death among a subpopulation 
of older patients on admission to hospital [10]. The tool was 
designed based on objective criteria available at the point 
of care, including the presence of advanced chronic illness, 
frailty parameters, history of hospital/ICU admission, physi-
ological deterioration criteria, and nursing home residency 
status (Supplement 1). CriSTAL requires minimal testing 
(ECG and urinalysis) so clinicians can enhance their con-
fidence in initiating timely sensitive end-of-life discussions 
on the most appropriate type and place of care for patients 
nearing the end of life. CriSTAL has been retrospectively 
evaluated for use in deteriorating inpatients subject to rapid 
response calls. Frailty was an independent predictor of death 
within 3 months [11] and a score of 6 has been deemed a flag 
for high risk of death [12].
Importance
Prediction of death within 3-months was considered an opti-
mal time as it would give opportunity for more than one dis-
cussion as it would not be driving decisions at critical times 
and would enable patients and/or families to elicit prefer-
ences and arrange affairs following discharge. One-year pre-
diction is likely to be modified by factors beyond clinical 
issues present during hospitalisation. Hence a model that 
yields accurate prediction of short-term death can inform 
patients and their caregivers about prognosis, and support 
management recommendations and shared decision making 
[13].
Goals of the investigation
The present study aimed to validate CriSTAL’s accuracy in 
estimating short-term mortality risk among on a wide range 
of patients with a variety of chronic illnesses presenting at 
emergency with exacerbations of chronic disease or inju-
ries. The Australian cohort served as the training cohort and 
the Danish hospital setting was selected as external valida-
tion cohort because they perceived the potential usefulness 
of CriSTAL in their hospitals after becoming aware of the 
tool in the development manuscript [10]. This study com-
pared the findings from an Australian patient subpopulation 
recruited in five teaching hospital EDs in 2015–2016 with a 
Danish patient population recruited in 2016 from four teach-
ing hospital EDs using the same study protocol [14].
Primary objectives
1. To determine the ability of the original CriSTAL tool to 
predict 90-day mortality.
2. To establish the ability of individual and combined 
parameters in the revised CriSTAL tool to predict death 
up to 90 days after initial assessment.
3. To determine the minimum number of variables which 
are sufficient to accurately predict death.
Secondary objective
4. To determine CriSTAL’s predictive ability for in-hospi-
tal death.
Methods
Study design and setting
This study is a prospective cohort where older patients pre-
senting at ED were assessed for eligibility and recruited by 
designated clinical researchers during business hours only in 
five Australian hospitals (derivation cohort) and four Danish 
hospitals (validation cohort). Details of design, recruitment, 
follow-up and analyses are presented in the protocol manu-
script, published elsewhere [14].
Measurements
Documentation of the CriSTAL tool [10] items relating to 
participants consisted of a designated ED nurse (eight) or 
medical student (four) searching for the clinical items on 
the medical record after securing written consent. The tool 
was translated into Danish and back translated into English 
language. Questions on any item missing on the medical 
record were asked of participants in the local language, and 
data entry also occurred in Danish language. Frailty was 
integral to the CriSTAL item list, and was measured con-
currently with two instruments: the Fried’s frailty pheno-
type instrument [15] and the Clinical Frailty Scale (CFS) by 
Rockwood [16], as both have been extensively validated and 
are known to be associated with future functional decline 
and death [17]. CFS was determined using clinical judgment 
based on observation of the patient supplemented with ques-
tions on activities of daily living. Fried’s score was deter-
mined based on self-report by patient or surrogate given the 
constrains of movement within the ED. Completion of the 
CriSTAL checklist took less than 5 min per patient. Base-
line and short-term follow-up risk factor data were entered 
into a web-based interface and transmitted securely to the 
university server of the faculty where the first author was 
based. Hospital discharge outcomes were ascertained by the 
recruiting personnel using a standard template soon after 
the discharge had been documented by the treating team. 
Follow-up was conducted by the recruiting nurses via tele-
phone contact with the participant’s household or nominated 
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surrogate’s telephone number (if the participant had died or 
was unavailable at the time of the call). The intention was 
to contact them as close as possible to 3 months after initial 
assessment. However, contact times varied due to patient, 
family or researchers factors. Details of the design are pub-
lished elsewhere [14]. The study methods and results are 
described in accordance with the TRIPOD checklist [18].
Selection of participants
Eligibility
Consecutive older patients (aged 65 years or above) pre-
senting at emergency departments (ED) for any non-elec-
tive reason for whom a decision has been made by a doctor 
to hospitalise or who had spent at least 1 night in the ED. 
Recruitment conducted over a 6-month study period or until 
minimum quota sample of 300 was reached in each partici-
pating hospital (July 2015 to March 2016 in Australia and 
January to July 2016 in Denmark). The follow-up period 
was up to July 2016 in Australia and to November 2016 in 
Denmark.
Exclusions
Patients otherwise eligible but with cognitive impairment, 
loss of consciousness or inability to speak the local language 
were excluded if their family/surrogate did not give consent 
for inclusion or could not act as informant. Patients being 
discharged on the same day were also considered ineligible.
Outcomes
The primary outcome was short-term mortality and the 
accuracy of this prediction based on the CriSTAL param-
eters. The secondary outcome was the ability of CriSTAL 
to predict in-hospital death.
Analysis
As there is no absolute consensus on the minimal require-
ment for dataset sample size for modelling, these large con-
temporary primary data collected on relevant older patients 
are anticipated to reflect the characteristics of our target 
population for reproducibility and generalizability of the 
model [19]. Parameters classified as unknown after medi-
cal record check were considered absent. No imputations 
were used for missing data. Analysis of sensitivity, specific-
ity, and positive/negative predictive value were conducted 
for individual variables and combinations of variables in 
backward elimination logistic regression models where the 
outcome was death at 3 months or in-hospital death. Fol-
lowing our a priori decision, age as continuous variable and 
sex remained in all models regardless of statistical signifi-
cance. Results only present the variables retained in the final 
models. Delays in locating patients for follow-up meant that 
some outcomes were ascertained beyond 3 months with half 
ascertained at 4 months in Australia. We hereby refer to 
the outcome of short-term death as this follow-up period of 
median 4 months but some participants’ status was ascer-
tained up to 6 months. However, Deaths were not included 
in the outcome if they occurred after 4 months. Ten thousand 
random bootstrap resamples were used to internally validate 
the models and estimate 95% confidence intervals. Areas 
under the receiver-operating characteristic (AUROC) curve 
were calculated to determine model discrimination [20]. 
Calibration was measured by regressing predicted prob-
abilities from the model with the observed values. During 
the internal validation in Australia using logistic regression 
directly with CriSTAL score as a summary measure yielded 
an AUROC of lower accuracy than the model using all the 
explanatory variables that make up the tool. In the external 
validation on Danish data, rather than using the summary 
score we modeled only the association of the CriSTAL 
components with the outcome. An acceptable model was 
defined as AUROC ≥ 70% [21]. All tests of significance used 
p < 0.05 (2-sided). All analyses were conducted in SAS ver-
sion 9.4. Further details of the analysis are presented in the 
protocol [14].
Results
Characteristics of study participants
A total of 2493 eligible people (1350 in Denmark and 1143 
in Australia) were identified for recruitment only during 
business hours of 8:00 a.m. to 5:00 p.m. on weekdays due 
to resource constraints. Some potentially eligible patients 
left the ED before there was opportunity to enroll them. In 
Australia 44% potentially eligible could be approached given 
the large numbers of older patients being admitted including 
at night, against the limited numbers of recruiters available, 
while in Denmark the rate was 72%. Details of recruitment, 
reasons for non-invitation or refusal and extent of follow-
up are presented in Fig. 1. Note that in-hospital death or 
absence or hospital discharge outcome did not preclude the 
follow-up call to the family for confirmatory information. 
Thus the final numbers include all who were not lost to 
follow-up regardless of survival status. Complete follow-
up data were available for 88.6% in Australia and 97% in 
Denmark.
Comparative risk profiles of the derivation and validation 
cohorts are presented in Table 1. On average the Danish 
cohort was 2 years younger and was less frail (according 
to Fried’s scale but not according to CFS), more affected 
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by cancer, CHF and COPD but with similar proportions of 
people suffering from two or more comorbidities. Yet, the 
Danish cohort was less likely to have been hospitalized in 
the previous year, stayed in hospital for longer periods, and 
had more patients discharged home with community sup-
port services. On admission in Australia, females were sig-
nificantly more frail (Fried score ≥ 3) than males (χ2 = 9.18, 
p = 0.0024) but not in Denmark (χ2 = 0.21, p 0.64). In both 
the Australian and Danish cohorts, the prevalence of not 
for resuscitation orders (4.8% and 4.6%, respectively) 
and advance health directives was low (0.44% and 1.6%, 
respectively).
There were no differential CriSTAL score or sex distribu-
tions between the participants and those lost to follow-up 
in either cohort, and no age differentials in the Australian 
cohort. However, the age distribution of the lost to follow-up 
in Denmark indicated that the youngest group (65–74 years) 
was more likely to be lost to follow-up (p = 0.024).
Short‑term comparisons between survivors 
and non‑survivors
Confirmed participants’ mortality at the end of the follow-
up period for all participants was 10.1% (116) in Australia 
and 13.6% (184) in Denmark. The median follow-up times 
were 124 days in Australia (IQR 105–170) and 97 in Den-
mark (IQR 92–149); and most of the deaths occurred within 
4 months (84% and 93% at 3 and 4 months, respectively in 
Australia; and 99% at both 3 and 4 months in Denmark). 
Those who died in hospital had significantly longer mean 
length of stay than their surviving counterparts in both 
health systems.
Fig. 1  Recruitment and follow-up flow-chart in five Australian and four Danish hospitals
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The deceased were significantly older, mean age 
82.5  years (95% CI 80.9–84.1) vs. 79.6  years (95% CI 
79.1–80.1) in Australia (t test = − 3.68, p = 0.0002); cor-
responding values for Denmark were mean age 81.1 years 
(95% CI 79.6–82.5) vs. 78.1 years (95% CI 77.6–78.5; t 
test = − 4.30, p < 0.0001). In both cohorts the deceased 
also had significantly higher CriSTAL scores (Fig.  2), 
with Australian mean 8.1 (95% CI 7.7–8.6 vs. 5.8 95% CI 
5.6–5.9) and Danish mean 7.1 (95% CI 6.6–7.5 vs. 5.5 95% 
CI 5.4–5.6). The deceased were significantly more frail as 
measured by ≥ 3 Fried parameters (χ2 = 101.9, p < 0.0001), 
and mean CFS score of 5.6 vs 4.2 (95% CI 5.3–5.9 vs. 95% 
CI 4.2–4.3, p < 0.0001) in Australia; the values for Denmark 
were ≥ 3 Fried parameters (χ2 = 157.7, p < 0.0001), and 
mean CFS 6.1 vs. 4.5 (95% CI 5.9–6.4 vs. 95% CI 4.4–4.6, 
p < 0.0001). The range, median and interquartile range of 
CriSTAL scores in Australia were 2–12, 6 (IQR 4–7) for 
survivors and 3–14, 8 (IQR 7–10) for the deceased. Cor-
responding values in Denmark were 2–13, 5 (IQR 4–7) for 
survivors and 2–13, 7 (IQR 5–9) for the deceased.
Short‑term predictors of death
Applying the Australian CriSTAL algorithm to the Danish 
data revealed that the Australian model under- predicts the 
probability of death for the European data (Fig. 3). That is, 
the model based on patients from five Australian hospitals 
was (as expected) not optimised for the patient population 
of four Danish hospitals. Calibration in the large was = 0.76, 
p < 0.001. Given these results, we fitted a model optimised 
for the Danish data based on their own patient information 
(Fig. 3 and Table 2 which include all patients with complete 
follow-up).
Table 1  Comparative risk 
profiles of the derivation 
(Australia) and validation 
(Denmark) cohorts
Australia: deceased by end of study 116; survived = 1026; Denmark: deceased by end of study = 184; sur-
vived = 1166
RRS rapid response system deterioration criteria to call an emergency team on admission
a Number and % within cohort IQR = interquartile range
b Mental Impairment includes one or more of the following: dementia, long term mental illness, disability 
from stoke, or acute behavioural changes
c Information on proteinuria 59% missing in Australia and 41.2% missing in Denmark
Risk factor
n (% of cohort)
Frequency  Australiaa
N = 1143
Frequency Denmark
N = 1350
Median age—years (IQR) 80 (73–86) 78 (76–85)
Female (%) (52.0) (53.0)
Median length of stay 3.0 days (95% CI 1.0–7.0) 6.0 days (5.6–6.3)
Nursing home resident 74 (10.3) 139 (10.3)
Advanced malignancy 64 (5.6) 127 (9.4)
Any mental  impairmentb 123 (10.8) 258 (19.1)
Dementia only 70 (6.1) 90 (6.7)
Proteinuriac 3 (0.26) 12 (0.8)
Chronic kidney disease 133 (11.6) 70 (5.2)
Fried frailty binary ≥ 1 979 (85.7) 876 (64.9)
Fried frailty score ≥ 3 357 (31.2) 251 (19.6)
CFS frailty ≥ 5 603 (52.8) 702 (52.0)
Congestive heart failure 146 (12.8) 242 (17.9)
Chronic obstructive pulmonary disease 179 (15.6) 327 (24.2)
New or previous myocardial infarction 126 (26.7) 131 (9.7)
New cerebrovascular accident 16 (1.4) 36 (2.7)
Chronic liver disease 19 (1.7) 29 (2.2)
Hypoglycaemia 9 (0.8) 13 (1.0)
Low urinary output 16 (1.4) 5 (0.4)
Abnormal ECG 457 (40.0) 483 (35.8)
Meet ≥ 2 RRS criteria 70 (6.1) 78 (5.8)
Hospital admission in the past year 671 (58.7) 658 (48.7)
ICU admission in the past 12 months 88 (7.7) 98 (7.3)
2 or more chronic conditions 175 (15.31) 218 (16.2)
Community services post-discharge 220 (19.3) 316 (23.4)
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After replacing the Fried frailty scale in CriSTAL with 
the CFS scale, the discriminant ability of the modified 
CriSTAL model for short-term death in Denmark improved 
(Table 2). There remained similarity in four of the predic-
tors of short-term outcome between Danish and Australian 
data: advanced malignancy, frailty, increasing age and male 
gender In the Australian model advanced malignancy carried 
a sixfold risk of death, whereas in the Danish model chronic 
liver disease carried the highest risk of death (fourfold). 
Frailty was associated with a twofold increased risk of short-
term death in Australia and slightly over 50% increased risk 
in Denmark (Table 2). In both cohorts, CriSTAL as a sum-
mary score with Fried as originally designed had lower accu-
racy in predicting short-term [Danish cohort AUROC 0.687 
(95% CI 0.640–0.735) and Australian cohort AUROC 0.768 
(0.721–0.814)] death than the accuracy observed when indi-
vidual CriSTAL parameters were examined.
In both the Australian and Danish models CriSTAL 
had optimal sensitivity (≥ 90%) at low death probabilities 
of 3–4% and optimal specificities (> 90%) at higher death 
probabilities above 20% (see selected cut-off probabilities 
in Supplement 2).
For the secondary outcome of in-hospital death predic-
tion CriSTAL had only moderate accuracy with AUROC of 
0.795 (95% CI 0.737–0.854) for the Australian cohort and 
0.682 (95% CI 0.624–0.751) for the Danish cohort (Sup-
plement 3). Sensitivity and PPV were low at probabilities 
of death of 25% and above, whereas specificity and NPV 
were generally high at all probabilities of 10% and above 
(Supplement 4).
Discussion
This validation study demonstrated that the CriSTAL clini-
cal prediction tool based on existing objective parameters 
had a good discriminant ability (AUROC 0.81 in Australia 
and 0.79 in Denmark) for identifying older patients at risk 
of death up to 4 months in nine hospitals. CriSTAL adds 
enhanced knowledge by providing a flag for high-risk and 
an individual probability of death based on personalised risk 
factors. After controlling for age and sex, a minimum of two 
variables—frailty and advanced malignancy—were signifi-
cantly associated with death in both settings. The distribu-
tion of CriSTAL scores on admission was higher for those 
who died than for survivors, indicating its usefulness in 
enhancing prognostic confidence. As we had used two frailty 
scales concurrently on admission, an incidental but impor-
tant finding was that modifying CriSTAL with the inclusion 
of the CFS frailty scale yielded a better predictive model for 
the Danish cohort, whereas the original CriSTAL incorpo-
rating Fried’s worked better for the Australian cohort. Frailty 
was also more strongly associated with short-term mortality 
in Australia than in Denmark, and since administration of 
the frailty instruments was equivalent, the different impact 
may be due to the differences in patient casemix or vari-
ability in the type of community support provided in the dif-
ferent health systems. This aspect was beyond the scope of 
our study.
Fig. 2  Distribution of CriSTAL scores for all patients by survival sta-
tus. Inpatients in five Australian hospital (a) and four Danish (b) hos-
pitals (N = 2493)
Fig. 3  Prediction of short-term mortality: comparison of AUROC for 
Australian internal validation, and Danish external validation
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Early identification of frail older people nearing the end 
of life is important to give patients and families time to 
prepare and opportunity to discuss values, preferences and 
avoid unacceptable treatments [22] including potentially 
preventable emergency re-attendances. CriSTAL is highly 
specific and different clinicians may choose different cut-off 
points to initiate end-of-life discussions depending on the 
predictive probability of death at which their certainty of 
prognosis is sufficiently reassuring. Advantages of the CriS-
TAL tool are its objective base, ready availability of param-
eters, ease and speed of administration (less than 5 min in 
our experience), and its applicability for non-disease-specific 
circumstances; it can be applied to a broad range of older 
patients with multiple chronic conditions admitted to medi-
cal or surgical wards. At the same time we acknowledge that 
it is yet to be determined whether objective prediction tools, 
even if brief, can be embedded in routine clinical practice in 
a busy emergency department environment.
In the Australian validation, CriSTAL used as a continu-
ous score was less accurate for predicting death than the 
model using independent CriSTAL tool components. A 
model separating the individual components is more useful 
for clinicians to initiate end-of-life discussions with selected 
patients about their personalized risk. Worldwide, we would 
expect that this would be a common minimum set of predic-
tors across different settings. Four of the original 29 vari-
ables were predictive of death both in Australian and Danish 
patients: male gender, increasing age, advanced malignancy 
and frailty. Other variables may be more or less predictive 
depending on the impact of health system resources, clinical 
practices, and patient casemix. Even missing parameters or 
sampling error can determine which contributing variables 
will end up in the final optimal model.
Very few clinical prediction rules are evaluated and made 
readily available at the point of care [23]. While the tool 
was implemented as a research project, this is the largest 
prospective study of effectiveness of the CriSTAL tool in 
predicting individual probabilities of short-term death in a 
real-life setting. Attempts to identify older patients at risk of 
death in emergency departments [9] to improve prognostic 
accuracy are reported in the literature for 30-day mortal-
ity [24] or 1-year prediction [25]. For short-term mortality 
Table 2  Modelling of short-term mortality using two frailty instruments within the CriSTAL tool for Danish data alone (external validation 
N = 1311) and in the Australian cohort (internal validation N = 1013)
Excludes those lost to follow-up by the end of the study
DK Denmark, Aus Australia
a Abnormally low and meeting calling criteria for rapid response call  (SaO2 ≤ 90%)
A. External validation (DK cohort) A. DK model with fried frailty scale B. DK model with CFS frailty scale
Effect OR 95% Wald
Confidence limits
p value OR 95% Wald
Confidence limits
p value
Intercept 0.0222 0.0128 0.0336 < 0.0001 0.0042 0.0016 0.0088 < 0.0001
Age 1.06 1.03 1.09 < 0.001 1.05 1.02 1.08 0.0004
Male 2.16 1.50 3.21 < 0.001 1.97 1.34 2.94 0.0006
Advanced malignancy 4.21 2.54 6.91 < 0.001 3.22 1.90 5.44 < 0.001
Oxygen  saturationa 2.04 1.39 3.01 0.0003 1.56 1.06 2.30 0.0266
Any mental impairment 1.87 1.22 2.89 0.0038
Frailty as fried 1.52 1.33 1.78 < 0.001
Frailty as CFS 1.65 1.46 1.90 < 0.001
AUROC 0.764 (0.727–0.810) 0.794 (0.755–0.837)
B. Internal derivation (Aus cohort) A. Aus model with fried frailty scale B. Aus model with CFS frailty scale
Effect OR 95% Wald
Confidence limits
p value OR 95% Wald
Confidence limits
p value
Intercept 0.007 0.003 0.014 < 0.001 0.00157 0.00045 0.00404 < 0.0001
Age 1.04 1.01 1.07 0.012 1.04 0.99 1.07 0.0385
Male 2.19 1.39 3.62 0.001 2.45 1.50 4.20 0.0008
Advanced malignancy 5.91 2.89 12.25 < 0.001 4.92 2.19 10.82 < 0.001
Nursing home residence 3.12 1.61 5.91 0.001
Frailty as Fried 2.15 1.75 2.75 < 0.001
Frailty as CFS 1.97 1.46 1.81 < 0.001
AUROC 0.825 (0.784–0.869) 0.809 (0.761–0.857)
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(3–4 months), our model results were better than those of 
risk stratification tools in France [26], Holland [8], and 
Japan [27]. Others have also found old age, multimorbidity, 
increasing age, frailty or cancer as common predictors of 
3-month mortality [26, 28–30], but no validation has been 
reported for some (Table 3). Slightly higher performance on 
3-month mortality prognosis was found in USA [31] with a 
prediction tool that involved blood tests.
While four core predictors were common across sub-
populations in Denmark and Australia, differences in other 
predictors due to variations in patient casemix [33], health 
system policies, and clinical practices [34] across countries 
limit the transportability [7] of CriSTAL beyond the patient-
related factors. The Danish health system provides higher 
level of community support that facilitates patient manage-
ment out of hospital whereas discharge to nursing home is 
avoided. It is possible that this explains why nursing home 
status was not a significant predictor of death in Denmark. 
In Australia much of the care at end of life happens in acute 
care, and nursing home is perceived as an alternative for 
chronic management of frail older people. Risk-adjustment 
for post-discharge factors such as non-clinical variables is 
recommended for fair comparisons of hospital performance 
across health systems [35], but this was beyond the scope of 
the present study.
Screening for risk of death and early identification of 
palliative care needs for advance care planning in emer-
gency departments continues to be an important strategy to 
deal with the anticipated growth in number of emergency 
presentations by frail older people [9]. The use of clini-
cal prediction rules to assist shared decision-making can 
improve process and outcomes when treatment choices 
are clear, but recommendations are known to be variously 
applied across clinical contexts [36]. High-risk CriSTAL 
scores are not intended to dictate management but to flag the 
need for discussion with patients and families on transition 
from active to palliative or comfort care when appropriate. 
The approach should ensure flexibility to accommodate dif-
fering priorities and disease trajectories. The next steps for 
translation of findings from our validation study into prac-
tice can include: monitoring of the prevalence of end-of-life 
discussions after identification of high risk; evaluation of 
impact of screening on the type and place of care pathways, 
changes in length of hospital stay post end-of-life discussion, 
and intensity of health service re-attendances; and doctor/
patient/family satisfaction with the use of the risk prediction 
tool. Investigation of the prevalence of high-risk as measured 
by CriSTAL among older patients not admitted to hospital 
are the subject of another study in general practice.
Strengths of this study include heterogeneous groups 
of patients presenting at hospital emergency departments, 
almost complete discharge outcomes (99.7%), and high 
follow-up retention rates and mid-term outcome ascertain-
ment (98%). The data were high quality with minimal miss-
ing items on potential predictors other than proteinuria. We 
used internationally accepted techniques for validation of 
clinical prediction models [37]. Bootstrapping, involving 
statistical model building from successive sub-sampling 
Table 3  Comparison of 
CriSTAL performance and 
predictors with other 3-month 
prediction tools
a This study ED emergency department patients, CKD chronic kidney disease, N/R not reported
Country, date, reference, 
prediction timeframe
Patient type and predictors AUROC 95% CI
Australia  2016a 65+ years-multimorbidity, ED
Male, old age, cancer, frailty
0.81 0.76–0.86
Denmark  2016a 65+ years-multimorbidity, ED
Male, old age, cancer, frailty, oxygen saturation
0.79 0.76–0.84
France 2015 [26] Older patients with CKD
Male, old age, poor mobility, cancer
0.76 0.75–0.77
Holland 2012 [8] 70+ years, ED patients
Disease severity, functional/cognitive impairment
0.74 0.67–0.80
Japan 2015 [27] Patients on terminal chemotherapy
40 + lab tests: Alb, LDH, neurtrophil count
0.77 N/R
USA 2012 [31] 60+ year with end-stage liver disease
Modified frailty index, serum sodium
0.82 N/R
Holland 2016 [28] Older patients discharged from ED
Low oxygen saturation, old age
N/R N/R
Brazil 2008 [29] Older patients post-hip fracture
Old age, Charlson multimorbidity
N/R N/R
Italy 2013 [30] Cognitively impaired older persons
Cancer and hospital adverse event
N/R N/R
USA 2016 [32] 55+ year adults in ED
Palliative performance score
N/R N/R
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(10,000 times) of the original sample ensured the reliability 
of results.
Limitations
The differences in the composition and operation of nurs-
ing home, emergency departments and community support 
between the two countries were not measured or accounted 
for and this may have played a role in some variations in the 
findings. The relatively small number of events (deaths) in 
the cohort in the anticipated timeframe limited our ability to 
present a wider range of predictive factors and probabilities of 
death with corresponding sensitivity and specificity. This was 
likely due to the age eligibility criterion set too low at 65-years 
of age rather than selection of older participants, and to exclu-
sion of patients with cognitive impairment for practical reasons 
in real-life survey settings [38]. The potential for selection bias 
exists as recruitment did not take place at night or on weekends 
due to resource constraints. It has been previously reported 
that patients arriving at the ED during those times have a more 
severe clinical profile and experience higher mortality over the 
next few days [39]. However, if patients admitted at night or on 
Sundays were in hospital during weekday recruitment times 
they were invited and recruited. The impact of the exclusion 
of these cases in our study may be an underestimation of the 
accuracy of mortality risk. The proportions of eligible peo-
ple actually recruited varied between settings given the high 
demand for services (including nights) in Australia and the 
limited number of staff recruiting participants. This approach 
may have missed a different type of patient seeking ED attend-
ance at night or on weekends. The limitation of enrolment dur-
ing business hours was present for both health systems and it 
is the nature of research in real-life environments with limited 
funding to cover all hours. Only small proportions of patients 
with cognitive impairment including dementia (11% in the 
Australian and 19% in the Denmark cohort) could be enrolled 
via surrogates. In retrospect, for larger number of events we 
could have recruited only sicker individual with higher prob-
abilities of death had we invited 80 + year-olds in the study, 
but the issue of inability to recruit without a surrogate would 
have remained. Proteinuria was often absent in Denmark and 
Australia so it had to be removed from the validation. Chronic 
disease predictors were based on recorded documentation and 
variability in completeness of prognostic variables by physi-
cians in routine care may have underestimated actual prev-
alence of risk factors on admission. Frailty indicators were 
self-reported rather than measured given the restrictions of 
mobility and practicalities of demonstrating physical func-
tioning in the hospital ED. The need for subjective self-report 
rather than measured frailty on admission is a well-recognised 
issue [40]. It is not uncommon in pragmatic studies in routine 
care, and its concordance with objectively measured frailty is 
highly satisfactory [41].
In summary, the CriSTAL screening tool demonstrated 
good discriminant power in predicting short-term mortality 
among older patients presenting at hospital emergency ser-
vices. In the hospital setting, frailty measured with the CFS 
scale has better discriminant power than Fried’s frailty score. 
This risk prediction tool is not intended to prescribe treatment 
decisions. The flags of male gender, old age, advanced malig-
nancy and frailty indicate opportunities for end-of-life discus-
sions, and if the tool can be embedded into routine practice it 
could enhance clinicians’ confidence in prognosis including 
recommendations for non-acute supportive terminal care. The 
threshold at which the discussion is initiated should be one 
where the risk of harm/benefit ratio of having the end-of-life 
discussion is optimal. Documenting objective items for the 
CriSTAL tool could be rapidly achieved using readily avail-
able parameters from medical records in routine practice. To 
optimize predictability we recommend either that risk adjust-
ments for health system influences be incorporated, or predic-
tor variables be examined within health systems rather than 
extrapolated from foreign algorithms due to these external 
influences beyond individual patient profiles.
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